Laddar populära aktier...
Redeye states the report beat its estimates on net sales and profitability.
Fiskars Q1 adjusted EBIT of EUR 25.1m 13% above LSEG Data & Analytics consensus expectations.
Redeye provides an update following the Q1 2024 report.
There has been a somewhat mixed news flow from Prolight after the close of Q1’24.
Redeye updates on Evolution post Q1-results which came in slightly stronger than our forecast, albei...
Sales +11%, adj. EBITA +16% vs. cons, +8% org. sales Cons to raise '24e adj.
Redeye comments on BioInvent's Q1 report 2024.
Føroya Banki (previously BankNordik) will publish its Q1 2024 report on 2 May.
Redeye updates its estimates and valuation following Lifco releasing its Q1 2024 report, which came ...
37% premium to date of strategic review, 8% discount to last close Equates to '24e-'26e EV/ARR of 4.
'24e-'26e sales up 2-1% Volume growth to continue into the year FVR of SEK 20-35 reiterated Q1: Str...
Strong y-o-y growth: EEs +18%, SCs +36%, sales +22% EBIT margin 23% (25%), ~33% adjusted for FX effe...
-4% organisk tillväxt kompenseras av Thebalux-förvärvet Med höga jämförelsetal och fortsatt svår mar...
Tumorad is in clinical phase 1, and today, Spago Nanomedical announced that Tumorad had promising re...
- Geographical diversity gives resilience - UK grew 6% org.